Aeterna Zentaris
AEZS
#10196
Rank
S$22.27 M
Marketcap
S$7.28
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): S-$2.77

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is S-$2.61. In 2022 the company made an earnings per share (EPS) of S-$5.95 a decrease over its 2021 EPS that were of S-$2.32.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)S-$2.77
2022S-$5.95157.14%
2021S-$2.32-41.48%
2020S-$3.96-64.46%
2019S-$11.13-240%
2018S$7.95-122.32%
2017S-$35.62-53.53%
2016S-$76.64-86.71%
2015S-$576.90-35.21%
2014S-$890.47-216.67%
2013S$763.26-123.3%
2012S-$3,276-40.8%
2011S-$5,534-6.45%
2010S-$5,915-27.91%
2009S-$8,205-61.61%
2008S-$21,37183.61%
2007S-$11,640-195.31%
2006S$12,212178.26%
2005S$4,389-330%
2004S-$1,908-80.05%
2003S-$9,56417.78%
2002S-$8,121515.93%
2001S-$1,318-68.6%
2000S-$4,199119.62%
1999S-$1,912-3.63%
1998S-$1,984

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
S$9.36-459.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
S$4.71-280.86%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
S$3.78-244.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
S-$0.46-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
S$6.22-338.66%๐Ÿ‡บ๐Ÿ‡ธ USA